TY  - GEN
AU  - Polee,M B
AU  - Tilanus,H W
AU  - Eskens,F A L M
AU  - Hoekstra,R
AU  - Van der Burg,M E L
AU  - Siersema,P D
AU  - Stoter,G
AU  - Van der Gaast,A
TI  - Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus
SN  - 0923-7534
PY  - 2003///1017
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Squamous Cell
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Cisplatin
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Esophageal Neoplasms
KW  - Esophagectomy
KW  - methods
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Paclitaxel
KW  - Probability
KW  - Prognosis
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdg328
ER  -